FR EA
1041-00004 · Solara Digital Infrastructure LP · Transaction Documents
draft-disclosure-schedules-template.docx DOCUMENT M&A / Corporate
32 / 36 ← → ✕
Contract analysis Extract to table

DISCLOSURE SCHEDULES

TO THE

STOCK PURCHASE AGREEMENT

Template for Completion by the Sellers

Prepared by Calderwood & Harkness LLP on behalf of Solara Fleet Holdings LLC (Buyer)

To be completed by Meridian FleetWorks, Inc. and its counsel, Hawthorne Kinsey & Alcott LLP, and delivered in connection with the Stock Purchase Agreement dated as of [●], 2026

CONFIDENTIAL DRAFT — FOR DISCUSSION PURPOSES ONLY

[●], 2026

This document and the information contained herein are confidential and are provided solely for the use of the parties to the Stock Purchase Agreement referenced herein. This document and its contents may not be reproduced, distributed, or disclosed to any third party without the prior written consent of Calderwood & Harkness LLP on behalf of Solara Fleet Holdings LLC. This document is subject to the attorney-client privilege and the work product doctrine. Receipt of this document by any person other than the intended recipients does not constitute a waiver of any applicable privilege.

Right-click to update Table of Contents

GENERAL INSTRUCTIONS AND CONVENTIONS

1. Purpose

These Disclosure Schedules (these "Disclosure Schedules") are delivered pursuant to, and form an integral part of, the Stock Purchase Agreement (the "Agreement") dated as of [●], 2026, by and among:

(i) Solara Fleet Holdings LLC, a Delaware limited liability company ("Buyer");

(ii) the stockholders of Meridian FleetWorks, Inc., a Delaware corporation (the "Company"), listed on the signature pages to the Agreement (each, a "Seller" and collectively, the "Sellers"); and

(iii) [●], as Stockholder Representative (the "Stockholder Representative").

Capitalized terms used but not otherwise defined in these Disclosure Schedules shall have the respective meanings ascribed to such terms in the Agreement. All references herein to "Sections" or "Articles" refer to the corresponding Sections and Articles of the Agreement, unless the context clearly indicates otherwise.

These Disclosure Schedules are intended to set forth the exceptions, qualifications, and supplementary information to the representations and warranties of the Sellers and the Company contained in Article [●] of the Agreement, and to satisfy any other disclosure obligations of the Sellers and the Company arising under the Agreement. Nothing in these Disclosure Schedules shall be deemed to broaden the scope of any representation or warranty contained in the Agreement.

2. Disclosure Conventions

The following conventions apply to the preparation, interpretation, and use of these Disclosure Schedules:

(a) Corresponding Section Numbers. Each Schedule set forth herein is numbered to correspond to the applicable Section of Article [●] (Representations and Warranties of the Sellers) of the Agreement. Sub-sections within each Schedule correspond, where applicable, to the sub-sections of the corresponding Section of the Agreement.

(b) Cross-Applicability of Disclosures. A matter disclosed on any particular Schedule shall be deemed to be disclosed with respect to, and shall be deemed to qualify, any other Schedule or representation or warranty to the extent the relevance of such disclosure to such other Schedule or representation or warranty is reasonably apparent on the face of such disclosure. Notwithstanding the foregoing, the Sellers and the Company shall use commercially reasonable efforts to cross-reference disclosures to all applicable Schedules, and the absence of a specific cross-reference shall not be deemed to limit the applicability of any disclosure.

(c) No Admission of Materiality. The inclusion of any item or matter in these Disclosure Schedules shall not constitute an admission or acknowledgment by the Sellers or the Company that such item or matter (i) is material or would reasonably be expected to be material, (ii) has had or would reasonably be expected to have a Material Adverse Effect, (iii) constitutes a breach or violation of any contract, Law, or order, or (iv) establishes any applicable threshold, standard of materiality, or dollar amount for purposes of any representation or warranty in the Agreement. The listing of any item in these Disclosure Schedules is made solely for the purpose of providing information and disclosures in connection with the representations and warranties contained in the Agreement.

(d) Headings. Headings and section references used in these Disclosure Schedules are for convenience of reference only and shall not affect the meaning, construction, or interpretation of these Disclosure Schedules or any provision hereof.

(e) Summaries Not Exhaustive. The items and information listed in these Disclosure Schedules are not intended to be exhaustive of all relevant details with respect to any particular disclosed matter. Where any item in these Disclosure Schedules is described by summary or reference to a document, agreement, or instrument, such summary or reference is qualified in its entirety by reference to the full text of the applicable document, agreement, or instrument, copies of which have been provided or made available to Buyer and its Representatives (including in the virtual data room maintained by the Company in connection with the transactions contemplated by the Agreement) or are attached as exhibits hereto.

(f) Knowledge Qualifier. Where information is disclosed to the "Knowledge" of the Company or any Seller, such disclosure is made in accordance with the definition of "Knowledge" set forth in the Agreement and is not intended to imply the existence of facts or circumstances beyond what is actually known by the individuals encompassed by such definition.

(g) Currency. Unless otherwise specified, all dollar amounts set forth in these Disclosure Schedules are expressed in United States dollars.

(h) Dates. Unless otherwise specified, all information set forth in these Disclosure Schedules is current as of the date hereof. The Sellers and the Company undertake to update or supplement these Disclosure Schedules in accordance with the terms of the Agreement, if and to the extent required thereunder.

3. Format Instructions for Preparers

The following instructions are directed to the Sellers and their counsel, Hawthorne Kinsey & Alcott LLP, in connection with the preparation and completion of these Disclosure Schedules:

(a) Bracketed Placeholders. All bracketed placeholder fields (indicated by "[Insert]" or "[●]") must be completed with the applicable information. No bracketed placeholder should remain in the final executed version of these Disclosure Schedules.

(b) Sufficient Specificity. Each item disclosed in these Disclosure Schedules should be described with sufficient specificity to permit Buyer and its Representatives to identify the disclosed matter, including, where relevant, the identity of the parties involved, applicable dates, monetary amounts, and a summary of the relevant terms, conditions, and circumstances.

(c) Attachments. Where these Disclosure Schedules indicate that copies of referenced documents are to be attached (including by use of the notation "Attach"), the Sellers and the Company shall attach true, correct, and complete copies of all such documents (including all amendments, supplements, side letters, and modifications thereto) as exhibits to these Disclosure Schedules. Where a document has previously been made available in the virtual data room, a reference to the applicable data room index number is sufficient, provided that the document remains accessible therein as of the date of delivery of these Disclosure Schedules.

(d) Cross-References. Where an item is responsive to more than one Schedule, the Sellers and the Company should clearly identify such cross-applicability by including a cross-reference notation (e.g., "See also Schedule [●]") in each applicable Schedule.

(e) Negative Disclosures. Where no responsive items exist with respect to a particular Schedule or sub-section thereof, the entry "None" or "Not applicable" should be inserted in the relevant field. No Schedule should be left blank.

(f) Delivery Format. The completed Disclosure Schedules should be delivered in both electronic format (.docx and .pdf) and hard copy, executed by the authorized signatories identified on the signature page hereof.

SCHEDULE 1 — DEFINITIONS

This Schedule 1 sets forth certain defined terms that are specific to these Disclosure Schedules and that supplement or modify the defined terms set forth in the Agreement. Except as otherwise provided below, all capitalized terms used in these Disclosure Schedules shall have the meanings given to them in the Agreement.

[Insert any Schedule-specific defined terms, or state "None."]

SCHEDULE [●] — ORGANIZATION, GOOD STANDING, AND QUALIFICATION

This Schedule sets forth information regarding the organization, good standing, and qualification of the Company, as required by Section [●] of the Agreement.

1. Legal Name of the Company:

[Insert full legal name of the Company]

2. State of Incorporation:

[Insert state of incorporation]

3. Date of Incorporation:

[Insert date of incorporation]

4. State File Number:

[Insert state file number assigned by the Secretary of State of the state of incorporation]

5. Foreign Qualifications:

The following table lists all jurisdictions in which the Company is qualified or licensed to do business as a foreign corporation, including the state of the Company's principal place of business, states in which the Company maintains offices or facilities, and states in which the Company has a sufficient nexus of business operations or employees to require qualification.

[List all jurisdictions in which the Company is qualified or licensed to do business. Include the state of the Company's headquarters, each state where the Company maintains an office or physical presence, and each state where the Company has significant business operations, employees, or other contacts that may create a requirement to qualify as a foreign corporation.]

6. Jurisdictions Requiring Qualification Where the Company Is Not Currently Qualified:

[Identify any jurisdictions in which the Company conducts business activities or otherwise has a nexus that may require qualification or licensure as a foreign corporation, but in which the Company is not currently qualified. If none, state "None."]

7. Attachments:

The following documents are attached or to be attached hereto as exhibits to this Schedule:

(a) Certificate of Good Standing (or equivalent certificate) from the Secretary of State of the Company's state of incorporation, dated within thirty (30) days of the date hereof.

(b) Certificates of Good Standing (or equivalent certificates) from the Secretary of State (or equivalent authority) of each foreign qualification jurisdiction listed in the table above, dated within thirty (30) days of the date hereof.

[If any such certificate has not yet been obtained as of the date of delivery of these Disclosure Schedules, note the status of the request and the expected date of receipt.]

SCHEDULE [●] — SUBSIDIARIES

This Schedule sets forth information regarding the Subsidiaries of the Company, as required by Section [●] of the Agreement.

[List all Subsidiaries of the Company, or state "None."]

1. Subsidiaries:

[For each Subsidiary, provide the full legal name, jurisdiction of organization or incorporation, the Company's direct or indirect percentage ownership interest, the type of legal entity (e.g., corporation, limited liability company, limited partnership), the total authorized capital (including authorized share classes and par values, if applicable), and the total outstanding or issued capital. If the Company holds its interest in any Subsidiary indirectly through one or more intermediate entities, describe the chain of ownership.]

2. Joint Ventures, Minority Equity Investments, and Partnership Interests:

[Describe any joint ventures, minority equity investments, partnership interests, or other equity or ownership interests held by the Company in any Person (other than Subsidiaries listed in the table above), including the identity of the relevant entity, the nature and percentage of the Company's interest, and a brief description of the arrangement. If none, state "None."]

SCHEDULE [●] — CAPITALIZATION

This Schedule sets forth information regarding the capitalization of the Company, as required by Section [●] of the Agreement.

Section (a) — Authorized, Issued, and Outstanding Capital Stock

The following table sets forth the authorized, issued, and outstanding capital stock of the Company as of the date hereof:

[Complete with all classes and series of capital stock of the Company, including common stock and each series of preferred stock. If any shares are held in treasury, indicate the number of treasury shares separately.]

Section (b) — Fully Diluted Capitalization Table

The following table sets forth the fully diluted capitalization of the Company as of the date hereof, giving effect to the exercise or conversion of all outstanding options, warrants, and other convertible or exercisable securities:

[List each record holder of equity securities of the Company, including all holders of common stock, preferred stock, and options or warrants. The total fully diluted share count should reconcile to [Insert] shares. If additional columns are needed (e.g., for warrants, convertible notes, or additional series of preferred stock), add such columns as appropriate.]

Section (c) — Options, Warrants, and Other Rights

1. Equity Incentive Plan(s):

The Company maintains the following equity incentive plan(s):

(i) Plan Name: [Insert name of equity incentive plan]

(ii) Date Adopted: [Insert date the plan was adopted by the Board of Directors and approved by the stockholders]

(iii) Total Shares Authorized Under the Plan: [Insert number] shares of Common Stock

(iv) Total Shares Subject to Outstanding Awards: [Insert number] shares of Common Stock

(v) Shares Available for Future Grant: [Insert number] shares of Common Stock

(vi) Weighted-Average Exercise Price of Outstanding Options: $[Insert] per share

(vii) Vesting Schedules: [Describe the standard vesting terms applicable to awards granted under the plan, e.g., "Options granted under the Plan generally vest over a four (4) year period, with twenty-five percent (25%) of the shares subject to each option vesting on the first anniversary of the vesting commencement date and the remaining seventy-five percent (75%) vesting in equal monthly installments over the succeeding thirty-six (36) months, subject to the optionee's continued service through each applicable vesting date."]

(viii) Acceleration Provisions: [Describe any single-trigger or double-trigger acceleration provisions applicable to outstanding awards under the plan, including any acceleration upon a change of control.]

[If the Company maintains more than one equity incentive plan, provide the above information for each plan.]

2. Individual Option Grants:

The following table sets forth all individual option grants outstanding under the Company's equity incentive plan(s) as of the date hereof:

[List all individual option grants, including grants to employees, officers, directors, consultants, and advisors. Where an option has been partially exercised, indicate the number of shares previously purchased upon exercise and the remaining unexercised balance.]

3. Warrants:

[List all outstanding warrants to purchase capital stock of the Company, including the holder, date of issuance, number of shares, exercise price, and expiration date. If none, state "None."]

4. Convertible Securities:

[List all outstanding convertible notes, SAFEs, or other convertible securities of the Company, including the holder, principal amount, conversion price or valuation cap, and maturity date. If none, state "None."]

Section (d) — Preemptive Rights, Anti-Dilution Rights, and Other Rights

[Describe any preemptive rights, rights of first refusal, co-sale rights (including tag-along and drag-along rights), anti-dilution protections (including weighted-average or full-ratchet anti-dilution provisions), registration rights (including demand registration rights and piggyback registration rights), information rights, board observation rights, or other rights relating to the capital stock of the Company. Include references to any stockholders' agreement, investor rights agreement, right of first refusal and co-sale agreement, voting agreement, or similar agreement, and identify the parties thereto and the date of such agreement. If none, state "None."]

Section (e) — Stock Transfer Restrictions

[Describe any contractual or other restrictions on the transfer of the Company's capital stock, including (i) legends appearing on stock certificates (or noted in the Company's stock ledger for uncertificated shares), (ii) lock-up agreements, (iii) market standoff provisions, (iv) rights of first refusal in favor of the Company or other stockholders, (v) restrictions contained in the Company's Certificate of Incorporation or Bylaws, and (vi) restrictions arising under applicable securities Laws. If none, state "None."]

SCHEDULE [●] — AUTHORITY; NO CONFLICT

This Schedule sets forth information regarding the authority of the Company and the Sellers to enter into the Agreement and the potential conflicts arising from the transactions contemplated thereby, as required by Section [●] of the Agreement.

Section (a) — Required Approvals

[List any approvals of the Board of Directors, stockholders, or other governing body of the Company required to authorize the execution, delivery, and performance of the Agreement and the consummation of the transactions contemplated thereby, including the following, as applicable:]

(i) Approval by the Board of Directors of the Company, including the specific resolutions adopted or to be adopted by the Board authorizing the Agreement and the transactions contemplated thereby.

(ii) Approval by the stockholders of the Company, including the requisite vote required (e.g., majority of outstanding shares, supermajority, or class vote) and the method of obtaining such approval (e.g., meeting of stockholders or action by written consent). Identify any stockholders whose consent is specifically required under the Company's organizational documents or any stockholder agreement.

(iii) Any other corporate or governance approvals required under applicable Law, the Company's Certificate of Incorporation or Bylaws, or any agreement to which the Company or any Seller is a party.

Section (b) — Conflicts

[Identify any conflicts with, or violations, breaches, or defaults (or events that, with notice or lapse of time or both, would constitute a breach or default) under, any of the following that would result from the execution and delivery of the Agreement or the consummation of the transactions contemplated thereby:]

(i) The Certificate of Incorporation, Bylaws, or other organizational documents of the Company or any Subsidiary.

(ii) Any contract, agreement, lease, license, instrument, note, mortgage, indenture, or other obligation to which the Company, any Subsidiary, or any Seller (in his, her, or its capacity as a stockholder of the Company) is a party or by which any of their respective properties or assets are bound.

(iii) Any order, judgment, injunction, decree, writ, stipulation, determination, or award to which the Company, any Subsidiary, or any Seller (in his, her, or its capacity as a stockholder of the Company) is subject.

(iv) Any Law applicable to the Company, any Subsidiary, or any Seller (in his, her, or its capacity as a stockholder of the Company) or any of their respective properties or assets.

[If no conflicts exist, state "None."]

SCHEDULE [●] — CONSENTS AND APPROVALS

This Schedule sets forth all consents, approvals, authorizations, filings, and notices required from or to any Governmental Authority or other third party in connection with the execution and delivery of the Agreement and the consummation of the transactions contemplated thereby, as required by Section [●] of the Agreement.

[Include all of the following categories of consents and approvals, as applicable:]

(a) Change-of-Control Consent Provisions. All change-of-control or assignment consent provisions contained in Material Contracts, including customer agreements, vendor agreements, technology and hosting agreements, and partnership agreements.

(b) Landlord Consents. All consents required from landlords under leases for the Company's leased real property, including any requirements for landlord approval of an assignment, sublease, or change of control.

(c) Government Filings. All filings, notices, or approvals required from any Governmental Authority, including, without limitation, any filing required under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act"), any state antitrust or competition filing, and any other regulatory filing or approval.

(d) Lender Consents. All consents or waivers required from lenders or creditors under the Company's credit agreements, loan agreements, or other financing arrangements.

(e) Other Third-Party Consents. All other consents, approvals, or waivers required from any third party, including consents required under intellectual property licenses, joint venture agreements, or other agreements to which the Company is a party.

[If no consents or approvals are required, state "None."]

SCHEDULE [●] — FINANCIAL STATEMENTS

This Schedule sets forth information regarding the financial statements of the Company, as required by Section [●] of the Agreement.

1. Financial Statements Attached:

The following financial statements of the Company are attached hereto as exhibits to this Schedule (collectively, the "Financial Statements"):

(i) Audited Financial Statements. The audited balance sheets of the Company as of [Insert fiscal year-end date], [Insert fiscal year-end date], and [Insert fiscal year-end date], and the related audited statements of income, stockholders' equity, and cash flows for the fiscal years then ended, together with the reports thereon of [Insert name of independent auditor], the Company's independent registered public accounting firm.

(ii) Unaudited Interim Financial Statements. The unaudited balance sheet of the Company as of [Insert interim date] (the "Most Recent Balance Sheet"), and the related unaudited statements of income and cash flows for the [Insert]-month period then ended (collectively, the "Interim Financial Statements").

2. Auditor's Reports — Qualifications, Modifications, or Exceptions:

[Identify any qualifications, modifications, "going concern" opinions, emphasis-of-matter paragraphs, or other exceptions contained in the reports of the Company's independent auditor with respect to the audited Financial Statements. If the auditor's reports contain no qualifications, modifications, or exceptions, state "None."]

3. Off-Balance-Sheet Arrangements and Liabilities:

[Describe any off-balance-sheet arrangements, liabilities, commitments, or obligations of the Company not reflected or reserved against in the Financial Statements, including any guarantees, contingent liabilities, variable interest entities, or structured finance transactions. If none, state "None."]

SCHEDULE [●] — ABSENCE OF CERTAIN CHANGES

This Schedule sets forth information regarding certain changes since the date of the Most Recent Balance Sheet, as required by Section [●] of the Agreement.

Since [Insert date of Most Recent Balance Sheet] (the "Balance Sheet Date"), the following events, changes, occurrences, or developments have occurred that, individually or in the aggregate, have had or would reasonably be expected to have a Material Adverse Effect, or that constitute exceptions to the representations and warranties set forth in Section [●] of the Agreement:

(a) Material Damage, Destruction, or Casualty Loss. [Describe any material damage, destruction, or casualty loss (whether or not covered by insurance) affecting the Company's properties, assets, or business since the Balance Sheet Date, or state "None."]

(b) Change in Accounting Methods or Practices. [Describe any change in the Company's accounting methods, principles, practices, or policies since the Balance Sheet Date, including any change required by, or made in connection with, changes to GAAP, or state "None."]

(c) Increase in Compensation or Benefits. [Describe any increase in the compensation, bonuses, commissions, or benefits payable or to become payable to any director, officer, employee, or consultant of the Company outside the ordinary course of business consistent with past practice since the Balance Sheet Date, or state "None."]

(d) Dividends and Distributions. [Describe any declaration, setting aside, or payment of any dividend or other distribution (whether in cash, stock, property, or otherwise) with respect to any shares of capital stock of the Company since the Balance Sheet Date, or state "None."]

(e) Incurrence of Indebtedness. [Describe any incurrence, assumption, or guarantee of any Indebtedness by the Company since the Balance Sheet Date outside the ordinary course of business, or state "None."]

(f) Disposition of Material Assets. [Describe any sale, transfer, lease, license, or other disposition of any material assets or properties of the Company since the Balance Sheet Date outside the ordinary course of business, or state "None."]

(g) Amendment to Organizational Documents. [Describe any amendment, modification, or restatement of the Certificate of Incorporation, Bylaws, or other organizational documents of the Company since the Balance Sheet Date, or state "None."]

(h) Other Material Changes. [Describe any other material change in the business, operations, assets, liabilities, financial condition, or results of operations of the Company since the Balance Sheet Date not otherwise disclosed above, or state "None."]

[If no exceptions exist with respect to any of the foregoing categories, state "None" for each applicable sub-section.]

SCHEDULE [●] — UNDISCLOSED LIABILITIES

This Schedule sets forth information regarding undisclosed liabilities of the Company, as required by Section [●] of the Agreement.

The following liabilities of the Company (whether absolute, accrued, contingent, or otherwise) are not reflected or reserved against in the Most Recent Balance Sheet included in the Financial Statements, other than liabilities incurred in the ordinary course of business consistent with past practice since the Balance Sheet Date:

[Include any known potential liabilities of the Company, including, without limitation, pending or threatened claims, litigation reserves, tax exposures or assessments, product warranty obligations, indemnification obligations, deferred revenue adjustments, and any other contingent or unliquidated liabilities. Where the amount of any liability cannot be reasonably estimated, provide a description of the nature of the liability and the basis for the Company's inability to estimate such amount.]

[If no undisclosed liabilities exist, state "None."]

SCHEDULE [●] — INDEBTEDNESS

This Schedule sets forth all Indebtedness of the Company as of the date hereof, as required by Section [●] of the Agreement.

[Include all outstanding loans (whether term loans or revolving credit facilities), lines of credit, notes payable (including intercompany notes), capital leases and finance leases, letters of credit, guarantees of third-party obligations, hedging or swap obligations, deferred purchase price obligations, and any other debt obligations of the Company. For each item of Indebtedness, include all material terms, including any financial covenants, events of default, cross-default provisions, and change-of-control provisions.]

Attachments:

[Attach copies of all credit agreements, promissory notes, security agreements, pledge agreements, guaranty agreements, intercreditor agreements, and related documents, including all amendments, waivers, and supplements thereto.]

SCHEDULE [●] — REAL PROPERTY

This Schedule sets forth information regarding the real property owned or leased by the Company, as required by Section [●] of the Agreement.

Section (a) — Owned Real Property

[List all real property owned by the Company, or state "None."]

[For each parcel of owned real property, identify the street address, a brief description of the property (e.g., type of facility, approximate square footage, primary use), the record title holder, and any mortgages, deeds of trust, liens, encumbrances, easements, covenants, restrictions, or other title defects affecting such property.]

Section (b) — Leased Real Property

[List all real property leased, subleased, or licensed by the Company.]

[For each leased property, provide all information requested in the table above. In the "Change-of-Control / Assignment Provisions" column, describe any restrictions on assignment or subletting and any provisions requiring landlord consent upon a change of control of the tenant. In the "Renewal Options" column, describe the terms of any renewal or extension options, including the notice period and rental rate adjustments applicable to any renewal term.]

Defaults, Disputes, and Pending Modifications:

[Identify any defaults (or events that, with notice or lapse of time or both, would constitute a default) by the Company or any landlord under any lease, any disputes between the Company and any landlord, and any pending or proposed modifications, amendments, or terminations of any lease. If none, state "None."]

Attachments:

[Attach copies of all leases, sublease agreements, amendments, landlord waivers, estoppel certificates, subordination agreements, non-disturbance agreements, and all other documents related to the Company's leased real property.]

SCHEDULE [●] — PERSONAL PROPERTY

This Schedule sets forth all material items of tangible personal property (other than intellectual Property) owned or leased by the Company, as required by Section [●] of the Agreement.

[List all material items of tangible personal property owned or leased by the Company with an individual value in excess of $[Insert threshold], or state "None."]

[For tangible personal property, include all material items of equipment, machinery, vehicles, furniture, fixtures, computer hardware, servers, and other physical assets. For leased items, identify the lessor, the term of the lease, and any purchase options or residual value guarantees.]

Attachments:

[Attach copies of any material equipment leases, including all amendments and supplements thereto.]

SCHEDULE [●] — INTELLECTUAL PROPERTY

This Schedule sets forth information regarding the intellectual property of the Company, as required by Section [●] of the Agreement.

Section (a) — Owned intellectual Property — Registrations

The following table lists all intellectual property registrations and applications owned by the Company:

[Include all patents and patent applications (utility and design), registered trademarks and trademark applications (including service marks), registered copyrights and copyright applications, and registered domain names. For each item, identify the current owner of record. If any registration or application has lapsed, expired, or been abandoned, include such item and note its status.]

Section (b) — Owned intellectual Property — Unregistered

[Describe all material unregistered intellectual property of the Company, including, without limitation:]

(i) Trade Secrets. [Describe any material trade secrets and proprietary information of the Company, including proprietary algorithms, formulas, methods, processes, techniques, and compilations of data. Do not disclose the substance of any trade secret in a manner that would compromise its confidential nature; instead, provide a general description sufficient to identify the nature and scope of the trade secret.]

(ii) Proprietary Software. [Describe all proprietary software developed by or for the Company, including the name, version, function, and primary programming language(s) of each material software application or platform. Identify whether such software is used internally, provided to customers, or both.]

(iii) Know-How. [Describe any material know-how, technical information, or expertise developed by the Company that is not otherwise captured by the foregoing categories.]

(iv) Databases. [Describe any material proprietary databases maintained by the Company, including fleet management databases, customer databases, telemetry data repositories, and analytics datasets.]

Section (c) — Licensed intellectual Property (Inbound)

The following table lists all intellectual property licensed to the Company by third parties:

[Include all third-party software licenses (including enterprise licenses, SaaS subscriptions, and shrink-wrap or click-through licenses for material software used in the Company's operations), open-source software components incorporated into the Company's products or services, and all other technology licenses. For open-source software, identify the specific open-source license type (e.g., MIT License, Apache License 2.0, GNU General Public License v2.0, GNU General Public License v3.0, BSD License) and describe how each component is used in the Company's products or services (e.g., linked, modified, distributed).]

Section (d) — Licensed intellectual Property (Outbound)

[Describe any grants, licenses, sublicenses, covenants not to sue, or other rights granted by the Company to any third party with respect to any Company intellectual Property, including the identity of the licensee, a description of the licensed intellectual property, the scope and nature of the license grant (exclusive or non-exclusive, field of use, territory), the term, and any fees or royalties payable. If none, state "None."]

Section (e) — IP Assignment Agreements

The following table lists all current and former employees and independent contractors who have contributed to the development of Company intellectual Property, together with the status of their intellectual property assignment agreements:

[Identify any individuals for whom IP assignment agreements are missing, incomplete, or otherwise deficient, and describe the nature and extent of each such individual's contributions to Company intellectual Property. Where a former employee or contractor contributed to Company intellectual Property but did not execute an IP assignment agreement, describe any steps taken by the Company to obtain such assignment or otherwise mitigate the risk.]

Section (f) — IP Disputes and Infringement

[Describe any pending or, to the Knowledge of the Company, threatened claims, disputes, oppositions, interferences, proceedings, or investigations relating to the Company's intellectual Property, including, without limitation:]

(i) Any allegation that the Company's products, services, or operations infringe, misappropriate, or otherwise violate the intellectual property rights of any third party.

(ii) Any allegation by the Company that a third party has infringed, misappropriated, or otherwise violated the Company's intellectual property rights.

(iii) Any opposition, cancellation, or invalidity proceeding relating to any of the Company's registered intellectual property.

(iv) Any demand letters, cease-and-desist notices, or correspondence relating to intellectual property disputes.

[If none, state "None."]

SCHEDULE [●] — MATERIAL CONTRACTS

This Schedule sets forth all Material Contracts of the Company, organized by category, as required by Section [●] of the Agreement.

Category (a) — Customer Contracts

Standard Form Customer Agreement: